The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: A randomized controlled trial

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 942-945

  Bock, Gerlies ^a   Prietl, Barbara ^a   Mader, Julia K ^a   Höller, Evelyne ^a   Wolf, Michael ^a   Pilz, Stefan ^a   Graninger, Winfried B ^a   Obermayer Pietsch, Barbara M ^a   Pieber, Thomas R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

cell function; Regulatory T cells; Vitamin D; Vitamin D supplementation

Indexed keywords

C PEPTIDE; COLECALCIFEROL; OLEOVIT D3; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADULT; C-PEPTIDE; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOMODULATION; INSULIN-SECRETING CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 80855124111     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1276     Document Type: Article

References (12)

1. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010; 39: 419-446.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
3. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010; 88: 441-450.
4. Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10: 849-859.
5. Hypponen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes Metab 2010; 12: 737-743.
6. Gorman S, Kuritzky LA, Judge MA, et al. Topically applied 1, 25-dihydro-xyvitamin D3 enhances the suppressive activity of CD4 + CD25+ cells in the draining lymph nodes. J Immunol 2007; 179: 6273-6283.
7. Jeffery LE, Burke F, Mura M, et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183: 5458-5467.
8. Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 2010; 12: 136-139.
9. Bourlon PM, Faure-Dussert A, Billaudel B. The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats. J Endocrinol 1999; 162: 101-109.
10. Gysemans C, Van Etten E, Overbergh L, et al. Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha, 25-dihydroxyvitamin-D3. Clin Exp Immunol 2002; 128: 213-220.
11. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
12. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.